AREXVY Recombinant Respiratory Syncytial Virus pre-fusion F protein vaccine 120 micrograms powder vial and suspension vial for suspension for injection Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arexvy recombinant respiratory syncytial virus pre-fusion f protein vaccine 120 micrograms powder vial and suspension vial for suspension for injection

glaxosmithkline australia pty ltd - recombinant respiratory syncytial virus pre-fusion f protein, quantity: 120 microgram - injection, powder for - excipient ingredients: polysorbate 80; sodium chloride; 3-o-desacyl-4'-monophosphoryl lipid a; water for injections; dioleoylphosphatidylcholine; quillaja saponaria saponin qs-21; cholesterol; trehalose dihydrate; dibasic potassium phosphate; dibasic sodium phosphate; monobasic potassium phosphate - arexvy is indicated for active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (rsv).,the use of this vaccine should be in accordance with official recommendations.

Vepured Formulation: Each I mL (dose) of vaccine contains: Recombinant Verotoxin 2e RP 21.50 * Suspension for Injection (IM) Filipīnas - angļu - FDA (Food And Drug Administration)

vepured formulation: each i ml (dose) of vaccine contains: recombinant verotoxin 2e rp 21.50 * suspension for injection (im)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated recombinant escherichia coli verotoxin vaccine (vet.) - suspension for injection (im) - formulation: each i ml (dose) of vaccine contains: recombinant verotoxin 2e rp 21.50 *

Recombitek C4/CV Each dose 1.0 mL of vaccine contains the following through expiration: Active Ingredients: Canarypox/ Canine distemper virus recombinant, CP258, Rentschler/Onderstepoort strain, at least ................................................................................... >106.4TCID50 Canine adenovirus type 2, Toronto A/26/61 strain, at least ...................... >104.3 TCID50 Canine parvovirus, 780916 strain, at least ............................................. >103.3 FAID50 Canine parainfluenza virus, D-008 strain, at least ................................... >103.9 TCID50 Canine coronavirus, K-378/51 strain, at least........................................... >103.6 TCID50 "TCID-Tissue Culture Infective Dose "FAID- Fluorescent Antibody Infective Dess Lyophilized Powder for Injection (IM/SC) Filipīnas - angļu - FDA (Food And Drug Administration)

recombitek c4/cv each dose 1.0 ml of vaccine contains the following through expiration: active ingredients: canarypox/ canine distemper virus recombinant, cp258, rentschler/onderstepoort strain, at least ................................................................................... >106.4tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least ...................... >104.3 tcid50 canine parvovirus, 780916 strain, at least ............................................. >103.3 faid50 canine parainfluenza virus, d-008 strain, at least ................................... >103.9 tcid50 canine coronavirus, k-378/51 strain, at least........................................... >103.6 tcid50 "tcid-tissue culture infective dose "faid- fluorescent antibody infective dess lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , canine coronavirus vaccine (ccv) (vet.) - lyophilized powder for injection (im/sc) - each dose 1.0 ml of vaccine contains the following through expiration: active ingredients: canarypox/ canine distemper virus recombinant, cp258, rentschler/onderstepoort strain, at least ................................................................................... >106.4tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least ...................... >104.3 tcid50 canine parvovirus, 780916 strain, at least ............................................. >103.3 faid50 canine parainfluenza virus, d-008 strain, at least ................................... >103.9 tcid50 canine coronavirus, k-378/51 strain, at least........................................... >103.6 tcid50 "tcid-tissue culture infective dose "faid- fluorescent antibody infective dess

Recombitek C8 Formulation: Each mL of reconstituted vaccine (dose) contains: Canine distemper virus recombinant CP258 (Onderstepoort Strain).............> 10^6.4 TCID50 Canine adenovirus type 2 (Toronto A/26/61 Strain)...............> 10^4.3 TCID50 Canine parvovirus (780916 Strain).................> 10^3.3 FAID50 Canine parainfluenza virus (D-008 Strain).................> 10^3.9 TCID50 Leptospira interrogans ser. Canicola (1503 P4 Strain)..................> 200 FTU Leptospira interrogans ser. Icterohaemorrhagiae (ST1518 Strain)..................> 200 FTU Leptospira interrogans ser. Grippotyphosa (SC4397 Strain)..................> 300 FTU Leptospira interrogans ser. Pomona (T262 Strain)..................> 300 FTU TCID-Tissue Culture Infective Dose FAID. Fluorescent Antibody Indoctive Dese FTU-Formazin Turbidity Units Lyophilized Powder for Injection (IM/SC) Filipīnas - angļu - FDA (Food And Drug Administration)

recombitek c8 formulation: each ml of reconstituted vaccine (dose) contains: canine distemper virus recombinant cp258 (onderstepoort strain).............> 10^6.4 tcid50 canine adenovirus type 2 (toronto a/26/61 strain)...............> 10^4.3 tcid50 canine parvovirus (780916 strain).................> 10^3.3 faid50 canine parainfluenza virus (d-008 strain).................> 10^3.9 tcid50 leptospira interrogans ser. canicola (1503 p4 strain)..................> 200 ftu leptospira interrogans ser. icterohaemorrhagiae (st1518 strain)..................> 200 ftu leptospira interrogans ser. grippotyphosa (sc4397 strain)..................> 300 ftu leptospira interrogans ser. pomona (t262 strain)..................> 300 ftu tcid-tissue culture infective dose faid. fluorescent antibody indoctive dese ftu-formazin turbidity units lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , l. interrogans ser. icterohaemorrhagiae , l. interrogans ser. grippotyphosa , l. interrogans ser. pomona vaccine (vet.) - lyophilized powder for injection (im/sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine distemper virus recombinant cp258 (onderstepoort strain).............> 10^6.4 tcid50 canine adenovirus type 2 (toronto a/26/61 strain)...............> 10^4.3 tcid50 canine parvovirus (780916 strain).................> 10^3.3 faid50 canine parainfluenza virus (d-008 strain).................> 10^3.9 tcid50 leptospira interrogans ser. canicola (1503 p4 strain)..................> 200 ftu leptospira interrogans ser. icterohaemorrhagiae (st1518 strain)..................> 200 ftu leptospira interrogans ser. grippotyphosa (sc4397 strain)..................> 300 ftu leptospira interrogans ser. pomona (t262 strain)..................> 300 ftu tcid-tissue culture infective dose faid. fluorescent antibody indoctive dese ftu-formazin turbidity units

Innovax-ILT Formulation: Each dose contains: Recombinant Marek's Disease Virus (HVT FC-126 Strain......... > 2248 PFU Infectious Laryngotracheitis Virus (D and I Glycoprotein, 138 Strain) PFU - Plaque Forming Unit Suspension for Injection (In-Ovo/SC) Filipīnas - angļu - FDA (Food And Drug Administration)

innovax-ilt formulation: each dose contains: recombinant marek's disease virus (hvt fc-126 strain......... > 2248 pfu infectious laryngotracheitis virus (d and i glycoprotein, 138 strain) pfu - plaque forming unit suspension for injection (in-ovo/sc)

msd animal health (phils.), inc.; distributor: n.a. - live recombinant marek's disease (md) virus , infectious laryngotracheitis (ilt) virus vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: recombinant marek's disease virus (hvt fc-126 strain......... > 2248 pfu infectious laryngotracheitis virus (d and i glycoprotein, 138 strain) pfu - plaque forming unit

Purevax Felv 1 dose of 1mL or 0.5 mL contains FeLV recombinant Canarypoxvirus (vCP97-10˄7.2CCID50 Suspension For Injection (Sc) Filipīnas - angļu - FDA (Food And Drug Administration)

purevax felv 1 dose of 1ml or 0.5 ml contains felv recombinant canarypoxvirus (vcp97-10˄7.2ccid50 suspension for injection (sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - feline leukemia of felv recombinant canarypox virus vaccine (vcp97) - suspension for injection (sc) - 1 dose of 1ml or 0.5 ml contains felv recombinant canarypoxvirus (vcp97-10˄7.2ccid50

Vaxxitek HVT + IBD + ND Formulation: Each dose contains: Marek's Disease Virus, Serotype 3, VHVT310 (Recombinant HVT, FC-126 Strain) ............... >5696 pfu Infectious Bursal Disease Viral Protein 2 Newcastle Disease Virus Fusion (F) Protein, Genotype VIID PFU - Plaque Forming Unit Suspension for Injection (In-Ovo/SC) Filipīnas - angļu - FDA (Food And Drug Administration)

vaxxitek hvt + ibd + nd formulation: each dose contains: marek's disease virus, serotype 3, vhvt310 (recombinant hvt, fc-126 strain) ............... >5696 pfu infectious bursal disease viral protein 2 newcastle disease virus fusion (f) protein, genotype viid pfu - plaque forming unit suspension for injection (in-ovo/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live recombinant marek's disease (md) virus , infectious bursal disease (ibd) virus , newcastle disease (nd) virus vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: marek's disease virus, serotype 3, vhvt310 (recombinant hvt, fc-126 strain) ............... >5696 pfu infectious bursal disease viral protein 2 newcastle disease virus fusion (f) protein, genotype viid pfu - plaque forming unit

SHINGRIX Recombinant Varicella Zoster Virus glycoprotein E antigen vaccine 50 micrograms powder vial and suspension vial for suspension for injection Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

shingrix recombinant varicella zoster virus glycoprotein e antigen vaccine 50 micrograms powder vial and suspension vial for suspension for injection

glaxosmithkline australia pty ltd - recombinant varicella zoster virus glycoprotein e antigen, quantity: 50 microgram - injection, powder for - excipient ingredients: sucrose; monobasic sodium phosphate dihydrate; dibasic potassium phosphate; polysorbate 80 - shingrix is indicated for the prevention of herpes zoster (hz) and post-herpetic neuralgia in: - adults 50 years of age or older; - adults 18 years of age or older at increased risk of hz.

ZARZIO SOLUTION FOR INJECTIONINFUSION IN A PREFILLED SYRINGE 30MU0.5ML Singapūra - angļu - HSA (Health Sciences Authority)

zarzio solution for injectioninfusion in a prefilled syringe 30mu0.5ml

sandoz singapore pte. ltd. - recombinant filgrastim - injection, solution - recombinant filgrastim 0.30mg/0.5ml

VIRBAGEN OMEGA 10 INTERFERON FOR DOGS AND CATS Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbagen omega 10 interferon for dogs and cats

virbac (australia) pty ltd - recombinant omega interferon of feline origin - parenteral liquid/solution/suspension - recombinant omega interferon of feline origin vaccine active 10.0 mu/ml - immunotherapy - cat | dog - adult | cat - queen | cat - tom | kitten - canine parvovirus | feline calicivirus | calicivirus (feline) | fcv | parvovirus